Morgan Stanley’s Covisint Corporation COVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-34,692
| Closed | -$85K | – | 6762 |
|
|
2017
Q2 | $85K | Buy |
34,692
+23,178
| +201% | +$48.4K | ﹤0.01% | 5698 |
|
|
2017
Q1 | $23K | Sell |
11,514
-3,029
| -21% | -$6.04K | ﹤0.01% | 6053 |
|
|
2016
Q4 | $27K | Sell |
14,543
-7,375
| -34% | -$15.9K | ﹤0.01% | 5931 |
|
|
2016
Q3 | $48K | Sell |
21,918
-2,432
| -10% | -$5.31K | ﹤0.01% | 5612 |
|
|
2016
Q2 | $53K | Buy |
24,350
+5,556
| +30% | +$10.8K | ﹤0.01% | 5515 |
|
|
2016
Q1 | $38K | Sell |
18,794
-51,098
| -73% | -$104K | ﹤0.01% | 5718 |
|
|
2015
Q4 | $175K | Sell |
69,892
-376,956
| -84% | -$853K | ﹤0.01% | 5155 |
|
|
2015
Q3 | $961K | Sell |
446,848
-26,421
| -6% | -$72.7K | ﹤0.01% | 4139 |
|
|
2015
Q2 | $1.55M | Buy |
473,269
+206,771
| +78% | +$490K | ﹤0.01% | 3855 |
|
|
2015
Q1 | $541K | Sell |
266,498
-240,141
| -47% | -$560K | ﹤0.01% | 4605 |
|
|
2014
Q4 | $1.34M | Buy |
506,639
+506,436
| +249,476% | +$1.45M | ﹤0.01% | 3907 |
|
|
2014
Q3 | $1K | Sell |
203
-53,999
| -100% | -$242K | ﹤0.01% | 6515 |
|
|
2014
Q2 | $264K | Buy |
54,202
+51,995
| +2,356% | +$325K | ﹤0.01% | 5016 |
|
|
2014
Q1 | $16K | Sell |
2,207
-122,601
| -98% | -$1.23M | ﹤0.01% | 6019 |
|
|
2013
Q4 | $1.57M | Buy |
+124,808
| New | +$1.59M | ﹤0.01% | 3566 |
|
Morgan Stanley's COVS Position: Q3 2017 in Review
Morgan Stanley sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 34,692 shares — an estimated $85K sold.
Morgan Stanley first reported a position in COVS in Q4 2013 and held it in 15 quarters. The position peaked at $1.57M in Q4 2013. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.
- Morgan Stanley reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
- Morgan Stanley sold 34,692 Covisint Corporation shares in Q3 2017, an estimated $85K.
- Morgan Stanley first reported a position in Covisint Corporation in Q4 2013 and held it in 15 quarters.
- Morgan Stanley's Covisint Corporation position peaked at $1.57M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.